AzurRx BioPharma Inc News - AZRX

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C...

AzurRx BioPharma CEO James Sapirstein to Present at 2021 BIO Digital

BOCA RATON, Fla., June 08, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the...

AzurRx BioPharma Doses First Patient In Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal ...

“RESERVOIR” trial to evaluate niclosamide’s ability to target SARS-CoV-2 in the GI tract Topline trial data...

UPDATE - FMW Media, Inc.’s “New to The Street” TV Announces 6 Interviews Being Broadcast on NEWSMAX TV, Sunday, June 06...

NEW YORK, June 04, 2021 (GLOBE NEWSWIRE) -- FMW Media’s “New to The Street” TV broadcasting its national...

FMW Media, Inc.’s “New to The Street” TV Announces 6 Interviews Being Broadcast on NEWSMAX TV, Sunday, June 06, 2021, H...

NEW YORK, June 04, 2021 (GLOBE NEWSWIRE) -- FMW Media’s “New to The Street” TV broadcasting its national...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) Registration No. 333-256476 PROSPECTUS ...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) Registration No. 333-256476 PROSPECTUS...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) Registration No. 333-256476 PROSPECTUS...

Securities Registration Statement (simplified Form) (s-3)

As filed with the Securities and Exchange Commission on May 26, 2021 Registration No...

AzurRx BioPharma to Present at Rocky Mountain Microcap Conference (May 26)

DELRAY BEACH, Fla., May 19, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the...

FMW Media, Inc.’s “New to The Street” TV Announces 8 Interviews Being Broadcast on NEWSMAX TV, Sunday, May 16, 2021, Ho...

NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) -- FMW Media’s “New to The Street” TV broadcasting its national...

FMW Media’s “New To The Street” Syndicated TV Show Features AzurRx BioPharma, Inc.

NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) -- FMW Media Corp. announces that its “New To The Street” business TV...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

AzurRx BioPharma Inc (AZRX)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

AZRX News

Current Report Filing (8-k)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

AzurRx BioPharma CEO James Sapirstein to Present at 2021 BIO Digital

AzurRx BioPharma Doses First Patient In Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal ...

UPDATE - FMW Media, Inc.’s “New to The Street” TV Announces 6 Interviews Being Broadcast on NEWSMAX TV, Sunday, June 06...

FMW Media, Inc.’s “New to The Street” TV Announces 6 Interviews Being Broadcast on NEWSMAX TV, Sunday, June 06, 2021, H...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Securities Registration Statement (simplified Form) (s-3)

AzurRx BioPharma to Present at Rocky Mountain Microcap Conference (May 26)

FMW Media, Inc.’s “New to The Street” TV Announces 8 Interviews Being Broadcast on NEWSMAX TV, Sunday, May 16, 2021, Ho...

FMW Media’s “New To The Street” Syndicated TV Show Features AzurRx BioPharma, Inc.

AZRX Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

AzurRx BioPharma Inc (AZRX) News

AzurRx BioPharma Inc (AZRX)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

AZRX News

Current Report Filing (8-k)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

AzurRx BioPharma CEO James Sapirstein to Present at 2021 BIO Digital

AzurRx BioPharma Doses First Patient In Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal ...

UPDATE - FMW Media, Inc.’s “New to The Street” TV Announces 6 Interviews Being Broadcast on NEWSMAX TV, Sunday, June 06...

FMW Media, Inc.’s “New to The Street” TV Announces 6 Interviews Being Broadcast on NEWSMAX TV, Sunday, June 06, 2021, H...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Securities Registration Statement (simplified Form) (s-3)

AzurRx BioPharma to Present at Rocky Mountain Microcap Conference (May 26)

FMW Media, Inc.’s “New to The Street” TV Announces 8 Interviews Being Broadcast on NEWSMAX TV, Sunday, May 16, 2021, Ho...

FMW Media’s “New To The Street” Syndicated TV Show Features AzurRx BioPharma, Inc.

AZRX Discussion

Your Recent History